HighTower Advisors’s ADMA Biologics ADMA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$640K Buy
35,156
+4,948
+16% +$90.1K ﹤0.01% 2314
2025
Q1
$599K Sell
30,208
-69,173
-70% -$1.37M ﹤0.01% 2304
2024
Q4
$1.7M Buy
99,381
+11,910
+14% +$204K ﹤0.01% 1612
2024
Q3
$1.75M Buy
87,471
+25,492
+41% +$509K ﹤0.01% 1600
2024
Q2
$692K Sell
61,979
-11,010
-15% -$123K ﹤0.01% 2084
2024
Q1
$482K Buy
72,989
+1,569
+2% +$10.4K ﹤0.01% 2299
2023
Q4
$326K Sell
71,420
-1,097
-2% -$5.01K ﹤0.01% 2623
2023
Q3
$258K Buy
72,517
+38,160
+111% +$136K ﹤0.01% 2703
2023
Q2
$126K Sell
34,357
-300
-0.9% -$1.1K ﹤0.01% 2997
2023
Q1
$114K Buy
34,657
+12,434
+56% +$40.9K ﹤0.01% 2883
2022
Q4
$86K Buy
22,223
+600
+3% +$2.32K ﹤0.01% 2914
2022
Q3
$53K Buy
+21,623
New +$53K ﹤0.01% 2827
2021
Q2
Sell
-12,360
Closed -$22K 2897
2021
Q1
$22K Buy
+12,360
New +$22K ﹤0.01% 2814